[1]
BUGGANA, S.J. et al. 2020. DESIGN AND SYNTHESIS OF NOVEL 2, 3-DISUBSTITUTED QUINAZOLINES: EVALUATION OF IN VITRO ANTICANCER ACTIVITY AND IN SILICO STUDIES. Asian Journal of Pharmaceutical and Clinical Research. 13, 1 (Jan. 2020), 174–179. DOI:https://doi.org/10.22159/ajpcr.2020.v13i1.36215.